Essential core activities, niaid preclin development support
Ended Awarded Last action
- Contract number
- HHSN27200001
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,085,963
Award facts
- Opportunity
-
- NIHAI2015035 Solicitation number
- Contract value 70% obligated
-
- $9,085,962.73 Current, with exercised options
- $13,047,649.73 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $154,735 | |
| Funding Only Action | -$207,809 | |
| Funding Only Action | -$10,906 | |
| Funding Only Action | $33,045 | |
| Exercise an Option | $1,912,456 | |
| Exercise an Option | $1,866,402 | |
| Exercise an Option | $1,821,904 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,778,848 | |
| Original award | $1,737,288 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $13,047,649.73 contract is for "ESSENTIAL CORE ACTIVITIES, NIAID PRECLIN DEVELOPMENT SUPPORT" and does not have a set-aside designation.
ABL is a foreign-owned, for-profit manufacturing company that specializes in the development of gene therapies, vaccines, oncolytics, and immunotherapies. The company has extensive experience supporting preclinical and clinical development programs for government agencies, academia, and industry. This delivery order is part of a larger $24 million Indefinite Delivery Vehicle (IDV) with NIAID for the Diagnostics Pre-Clinical Services Program, as well as other IDVs with NIAID, the National Institute of Neurological Disorders and Stroke, and the National Cancer Institute, collectively valued at over $270 million. Through these vehicles, ABL provides a range of services including cGMP manufacturing, process development, analytical testing, and project management for infectious disease countermeasures and other medical products.
Quick answers
Who was awarded contract HHSN27200001?
HHSN27200001 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 8, 2017.
How much is contract HHSN27200001 worth?
The government has obligated $9,085,963 on HHSN27200001. Its potential value, with all options, is $13,047,650.
Is contract HHSN27200001 an order under another contract?
Yes. HHSN27200001 is a delivery order under HHSN272201700010I, an indefinite delivery contract.
Was contract HHSN27200001 competed?
The extent of competition for HHSN27200001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award